RSA, Stratus, SimpliVity, & More from the Boston Deals Roundup

9/26/12Follow @xconomy

Acquisitions in the software space were big in the past week, as were financing deals for other New England IT startups.

—RSA, the Bedford, MA-based security software division of EMC (NYSE: EMC), announced last week that it acquired Silicium Security, a Montreal-based developer of endpoint monitoring technology. Terms of the deal were not disclosed, but Silicium will keep its same staff and operations in Montreal.

—Boston-based DNA sequencing tech startup Pathogenica inked an exclusive partnership with Life Technologies (NASDAQ: LIFE) to co-market and distribute its hospital-acquired infection biodetection kit in Europe, the Middle East, and Africa.

—A report from the data firm CB Insights showed that in the three months that ended in June, corporate venture groups invested $80 million across 12 deals in Massachusetts. That still put the Bay State at a distant second behind California, which accounted for 8 percent of all corporate venture deals and 75 percent of the capital invested.

—Westborough, MA-based IT startup SimpliVity nabbed a $25 million Series B round led by Kleiner Perkins Caufield & Byers. Return SimpliVity investors Charles River Ventures and Accel Partners were also part of the investment.

—DocTrackr, a 2012 graduate of TechStars Boston and resident of Dogpatch Labs in Cambridge, received a $1.7 million venture investment from Polaris Venture Partners at a pre-money valuation of less than $10 million, according to a recent Wall Street Journal report. The startup develops mobile software for remotely accessing digital documents.

—Stratus Technologies, a Maynard, MA-based maker of hardware and software for preventing application downtime, said that it is acquiring Littleton, MA-based Marathon Technologies. The price tag of the deal wasn’t disclosed, but employees of Marathon, which makes high availability software, will be offered jobs at Stratus, according to the announcement.

By posting a comment, you agree to our terms and conditions.